Avacta Group (LON:AVCT) Share Price Passes Above 200-Day Moving Average – What’s Next?

Shares of Avacta Group Plc (LON:AVCT) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 60.97 and traded as high as GBX 63. Avacta Group shares last traded at GBX 61, with a volume of 3,769,863 shares changing hands.

Wall Street Analyst Weigh In

Separately, Peel Hunt reaffirmed a “buy” rating and issued a GBX 99 target price on shares of Avacta Group in a report on Monday, October 13th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of GBX 99.

Avacta Group Price Performance

The stock has a market capitalization of £266.96 million, a price-to-earnings ratio of -3.48 and a beta of 1.12. The company has a current ratio of 1.29, a quick ratio of 4.96 and a debt-to-equity ratio of 52.53. The company’s 50 day moving average is GBX 63.14 and its 200 day moving average is GBX 60.97.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).